These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28939178)

  • 1. Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineation.
    Lim Joon D; Lim A; Schneider M; Hiew CY; Lawrentschuk N; Sengupta S; Foroudi F; Jenkins T; Angus D; Wada M; Chao M; Khoo V
    Radiother Oncol; 2017 Oct; 125(1):113-117. PubMed ID: 28939178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
    Sefrova J; Odrazka K; Paluska P; Belobradek Z; Brodak M; Dolezel M; Prosvic P; Macingova Z; Vosmik M; Hoffmann P; Louda M; Nejedla A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):911-8. PubMed ID: 21420244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
    Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
    Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
    Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrence map to guide target volume delineation after radical prostatectomy.
    Wang J; Kudchadker R; Choi S; Pettaway CA; Choi H; Hobbs BD; Occena MC; McGuire SE; Pugh TJ; Hoffman K; Mahmood U; Kuban DA
    Pract Radiat Oncol; 2014; 4(6):e239-46. PubMed ID: 25407875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study.
    Cassidy RJ; Yang X; Liu T; Thomas M; Nour SG; Jani AB
    Med Dosim; 2016 Winter; 41(4):339-343. PubMed ID: 27745996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative radiotherapy in prostate cancer: the case of the missing target.
    Croke J; Malone S; Roustan Delatour N; Belanger E; Avruch L; Morash C; Kayser C; Underhill K; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1160-8. PubMed ID: 22270169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Choice of optimal margins in prostate conformal radiotherapy].
    Khalifa J; Commandeur F; Bachaud JM; de Crevoisier R
    Cancer Radiother; 2013 Oct; 17(5-6):461-9. PubMed ID: 23973458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence.
    El Kabbaj O; Robin P; Bourhis D; Dissaux G; Rosenfelder N; Valeri A; Fournier G; Salaun PY; Pradier O; Malhaire JP; Abgral R; Schick U
    Acta Oncol; 2018 Mar; 57(3):375-381. PubMed ID: 28984165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.
    Miralbell R; Vees H; Lozano J; Khan H; Mollà M; Hidalgo A; Linero D; Rouzaud M
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):356-61. PubMed ID: 17236961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy.
    Yeung AR; Vargas CE; Falchook A; Louis D; Olivier K; Keole S; Yeung D; Mendenhall NP; Li Z
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1426-33. PubMed ID: 18762391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: time reduction and cost benefit.
    Zorn KC; Trinh QD; Jeldres C; Schmitges J; Widmer H; Lattouf JB; Sammon J; Liberman D; Sun M; Bianchi M; Karakiewicz PI; Denis R; Gautam G; El-Hakim A
    BJU Int; 2012 May; 109(10):1526-32. PubMed ID: 22221566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
    Michalski JM; Lawton C; El Naqa I; Ritter M; O'Meara E; Seider MJ; Lee WR; Rosenthal SA; Pisansky T; Catton C; Valicenti RK; Zietman AL; Bosch WR; Sandler H; Buyyounouski MK; Ménard C
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):361-8. PubMed ID: 19394158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.
    Nguyen DP; Giannarini G; Seiler R; Schiller R; Thoeny HC; Thalmann GN; Studer UE
    BJU Int; 2013 Aug; 112(4):E243-9. PubMed ID: 23186331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of prostate fossa ultrasonography in the diagnosis of local recurrence after radical prostatectomy in case of PSA failure].
    Roscigno M; Scattoni V; Raber M; Consonni P; Montorsi F; Pasta A; Bertini R; Colombo R; Da Pozzo L; Freschi M; Rigatti P
    Arch Ital Urol Androl; 2002 Dec; 74(4):304-8. PubMed ID: 12508759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy.
    Park JS; Park W; Pyo HR; Park BK; Park SY; Choi HY; Lee HM; Jeon SS; Seo SI; Jeong BC; Jeon HG
    Radiother Oncol; 2014 Feb; 110(2):240-4. PubMed ID: 24485354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy.
    Wiltshire KL; Brock KK; Haider MA; Zwahlen D; Kong V; Chan E; Moseley J; Bayley A; Catton C; Chung PW; Gospodarowicz M; Milosevic M; Kneebone A; Warde P; Ménard C
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1090-9. PubMed ID: 17967303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy.
    Dowling JA; Lambert J; Parker J; Salvado O; Fripp J; Capp A; Wratten C; Denham JW; Greer PB
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e5-11. PubMed ID: 22330995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.